- Home
- NVCR vs NVST Comparison
NVCR vs NVST Comparison
Compare NVCR & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- NVST
- Stock Information
- Founded
- NVCR 2000
- NVST 2018
- Country
- NVCR Jersey
- NVST United States
- Employees
- NVCR N/A
- NVST N/A
- Industry
- NVCR Medical/Dental Instruments
- NVST Medical/Dental Instruments
- Sector
- NVCR Health Care
- NVST Health Care
- Exchange
- NVCR Nasdaq
- NVST Nasdaq
- Market Cap
- NVCR 3.0B
- NVST 3.3B
- IPO Year
- NVCR 2015
- NVST 2019
- Fundamental
- Price
- NVCR $30.97
- NVST $18.90
- Analyst Decision
- NVCR Buy
- NVST Hold
- Analyst Count
- NVCR 5
- NVST 14
- Target Price
- NVCR $33.40
- NVST $20.79
- AVG Volume (30 Days)
- NVCR 1.9M
- NVST 2.1M
- Earning Date
- NVCR 10-30-2024
- NVST 02-05-2025
- Dividend Yield
- NVCR N/A
- NVST N/A
- EPS Growth
- NVCR N/A
- NVST N/A
- EPS
- NVCR N/A
- NVST N/A
- Revenue
- NVCR $577,738,000.00
- NVST $2,503,300,000.00
- Revenue This Year
- NVCR $19.13
- NVST N/A
- Revenue Next Year
- NVCR $5.38
- NVST $2.86
- P/E Ratio
- NVCR N/A
- NVST N/A
- Revenue Growth
- NVCR 14.63
- NVST N/A
- 52 Week Low
- NVCR $11.70
- NVST $15.15
- 52 Week High
- NVCR $34.13
- NVST $25.64
- Technical
- Relative Strength Index (RSI)
- NVCR 60.66
- NVST 38.44
- Support Level
- NVCR $29.85
- NVST $17.70
- Resistance Level
- NVCR $34.13
- NVST $18.88
- Average True Range (ATR)
- NVCR 2.00
- NVST 0.72
- MACD
- NVCR -0.33
- NVST -0.22
- Stochastic Oscillator
- NVCR 44.92
- NVST 30.85
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.